Shortage of Shots That Protect Babies Against RSV Prompts CDC Alert

said nirsevimab should be reserved for infants with underlying health conditions and those younger than 6 months old.

“We are going to protect some children from RSV this year. We're not going to be able to protect as many as we'd hoped, and that's frustrating,” Dr. Buddy Creech, a pediatrician at Vanderbilt and president of the Pediatric Infectious Disease Society, toldages 8 to 19 months old should not receive Beyfortus because they are eligible for an older medication known as palivizumab (, which can make it hard for infants to breathe and eat.

About 81% of babies who needed intensive care for RSV last year had no underlying medical conditions and were born full term, according to a recent study published in the journalSome pediatricians were reluctant to stock the shots over concern about cost and how much insurance companies would reimburse them, making it harder for parents to locate Beyfortus,launches, demand for this product, especially for the 100- mg doses used primarily for babies born before the RSV season, has been higher...

“While deliveries of 100-mg doses continue, new orders are not being taken by Sanofi at this time,” the company told“We knew there were going to be many barriers to implementation of nirsevimab that we were anticipating, and pediatricians have been working hard to overcome those barriers, but we were assured by the manufacturer that supply would not be one of the barriers,” said Dr.

The CDC expects more doses will be available every 2 to 3 weeks, including both the 50- and 100-milligram products,Learn top parenting tricks for calming crying, colicky, and fussy newborns and babies from this WebMD slideshow.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC Warns of Shortage of RSV Shots to Protect BabiesDemand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and...
Source: NEWSMAX - 🏆 16. / 71 Read more »

A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Source: KPRC2 - 🏆 80. / 68 Read more »

A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Source: WOKVNews - 🏆 247. / 63 Read more »